Scholarlink

<p>Genital herpes, caused by the herpes simplex virus (HSV), is one of the most common sexually transmitted infections worldwide and the leading cause of genital ulcers. The virus is globally primarily transmitted by HSV‑2, although HSV‑1, especially in Europe, is increasingly recognized as a&#xa0;cause of genital first-episode infections. Many infections are asymptomatic, making unnoticed viral shedding the most frequent mode of transmission. Infection is preferably confirmed using polymerase chain reaction (PCR) from intact vesicles. Early and comprehensive patient education regarding symptoms, treatment options, and potential implications for sexual health is of great importance. Antiviral therapy, preferentially with acyclovir and valacyclovir can reduce both the severity and duration of the infection. For recurrent infections, suppressive antiviral treatment is recommended to decrease the frequency of recurrences and the transmission risk. Specific recommendations should be followed for special patient groups such as pregnant women and immunocompromised individuals.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Management des Herpes genitalis

  • 期刊论文

  • 发表日期：

    2026年2月13日

查看全文
  • Carla Dewald,
  • Robin Fischer,
  • Daniel Smarsly,
  • Luisa Bopp

摘要

Genital herpes, caused by the herpes simplex virus (HSV), is one of the most common sexually transmitted infections worldwide and the leading cause of genital ulcers. The virus is globally primarily transmitted by HSV‑2, although HSV‑1, especially in Europe, is increasingly recognized as a cause of genital first-episode infections. Many infections are asymptomatic, making unnoticed viral shedding the most frequent mode of transmission. Infection is preferably confirmed using polymerase chain reaction (PCR) from intact vesicles. Early and comprehensive patient education regarding symptoms, treatment options, and potential implications for sexual health is of great importance. Antiviral therapy, preferentially with acyclovir and valacyclovir can reduce both the severity and duration of the infection. For recurrent infections, suppressive antiviral treatment is recommended to decrease the frequency of recurrences and the transmission risk. Specific recommendations should be followed for special patient groups such as pregnant women and immunocompromised individuals.